Brief: Adial Pharmaceuticals- On Feb 28, Got Notification From Nasdaq Granting Request For 180-Day Extension To Regain Compliance With Min Bid Price Requirement

Azora Therapeutics

02/03/2023 12:21

Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS- ON FEB 28, GOT NOTIFICATION FROM
NASDAQ
GRANTING REQUEST FOR 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH
MIN BID PRICE REQUIREMENT

Source text for Eikon:  ID: 
Further company coverage:  ADIL.O